Ice-NYSE Euronext: Good or bad for margin offsets?

Ice’s December announcement of a planned $8.2 billion acquisition of NYSE Euronext sets up a battle for over-the-counter clearing supremacy in the US between Ice-NYSE and CME Group. The first shots are about to be exchanged over cross-margining. Peter Madigan reports

wall street black and white
New York Stock Exchange Building

So many new requirements are being placed on the derivatives market – mandatory clearing for standardised derivatives, with its attendant initial and variation margin calls, for instance, plus the expected collateral-posting obligation for uncleared trades – that users are looking for ways to squeeze out every possible cost saving they can. In that sense, the revelation in December that Atlanta-based Ice hopes to acquire NYSE Euronext may worry some.

On one hand, the $8.2 billion acquisition

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here